Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (17) , 3853-3856
- https://doi.org/10.1016/j.bmcl.2005.05.121
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1Bioorganic & Medicinal Chemistry Letters, 2005
- Erratum: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonistNature Medicine, 2002
- T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonistEuropean Journal of Pharmacology, 2002
- Response to Novelty After i.c.v. Injection of Melanin-Concentrating Hormone (MCH) in RatsPhysiology & Behavior, 1999
- Mice lacking melanin-concentrating hormone are hypophagic and leanNature, 1998
- Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on Body WeightEndocrinology, 1997
- Behavioral effects of α-MSH and MCH after central administration in the female ratPeptides, 1996
- Characterization of a human gene related to genes encoding somatostatin receptorsFEBS Letters, 1996
- A role for melanin-concentrating hormone in the central regulation of feeding behaviourNature, 1996
- Characterization of Melanin-Concentrating Hormone from Rat Hypothalamus*Endocrinology, 1989